Providence Health and Services
  Home  |  Health Plans  |  Providers  |  Programs & Services  |  Hospitals & Clinics  |  Health Info  |  Employment  |  Foundations

Site Search
myProvidence:
Login
Register
 
 

 

Publications: Craig R. Nichols, M.D.
 

To view related abstracts of these publications, search the PubMed database.

  1. Nichols C, Hoffman R, Einhorn L, Williams S, Wheeler L, Garnick M. Hematologic malignancies associated with primary mediastinal germ cell tumors. Proc Am Soc Clin Oncol 1985;4:96.
  2. Jayaram HN, Pillwein K, Nichols CR, Hoffman R, Weber G. Selective sensitivity to tiazofurin of human leukemic cells. Biochem Pharmacol 1986;35:2029-2032.
  3. Nichols CR, Palmer C, Heerema N, Loehrer PJ, Williams SD, Einhorn LH. Klinefelter syndrome associated with mediastinal germ cell tumor. J Clin Oncol 1987;5:1290-1294.
  4. Tricot GT, Jayaram HN, Nichols CR, et al. Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute leukemia. Cancer Res 1987;47:4988-4991.
  5. Nichols CR, Loehrer PJ, Greist A, Hoffman R. Salvage chemotherapy for lymphoma with VP-16, ifosfamide and cisplatin. Med Pediatr Oncol 1988;16:12-16.
  6. Loehrer PJ, Williams SD, Nichols CR. Ifosfamide plus 5-FU in the treatment of metastatic adenocarcinoma of the pancreas. Cancer Treat Rep 1987;71:1115-1116.
  7. Nichols CR, Tricot GJ, Williams SD, et al. Dose intensive chemotherapy in refractory germ cell cancer; A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 1989;7:932-939.
  8. van Besien K, Nichols C, Tricot G, Akard L, Cheerva A, Jansen J. Characteristics of engraftment after repeated autologous bone marrow transplantation (ABMT). Blood (Suppl I) 1988;71:411A.
  9. Tricot GT, Jayaram HN, Lapis E, et al. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5' phosphate dehydrogenase activity. Cancer Res 1989;49:3696-3701.
  10. Nichols CR, Saxman S, Williams SD, et al. Primary mediastinal nonseminomatous germ cell tumors: A modern single institution experience. Cancer 1990;65:1641-1646.
  11. Nichols CR, Roth BJ, Heerema NA, Griep J, Tricot G. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990;322:1425-1429.
  12. Wright CD, Kesler KA, Nichols CR, et al. Primary mediastinal nonseminomatous germ cell tumors: Results of a multimodality approach. J Thorac Cardiovasc Surg 1990;99:210-217.
  13. Saxman S, Nichols C, Miller M, et al. Mediastinal yolk sac tumor. The Indiana University experience; 1976-1988. J  Thorac Cardiovas Surg 1991;102:913-916.
  14. Loehrer P, Greger H, Weinberger M, et al. Knowledge and beliefs about cancer in a socioeconomically disadvantaged population. Cancer 1991;68:1665-1671.
  15. Broun E, Tricot G, Akard L, Nichols C, Cheerva A, Jansen J. Treatment of refractory lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-followed by autologous bone marrow transplantation. Bone Marrow Transplant 1990;5:341-344.
  16. Nichols C, Williams S, Loehrer P, et al. Randomized study of cisplatin dose-intensity in advanced germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 1991;9:1163-1172.
  17. Nichols CR. Mediastinal germ cell tumors: Clinical features and biological correlates. Chest 1991;99:472-479.
  18. Broun E, Nichols C, Einhorn L, Tricot G. Salvage therapy with high dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors. Cancer 1991;68:1513-1515.
  19. Murphy B, Conces D, Nichols C. Thymic Hyperplasia after chemotherapy:  Two cases reports and a literature review. Ind Med 1991;84:624-627.
  20. Nichols C, Roth B, Williams S, et al. No evidence of cardiovascular complications of chemotherapy for testicular cancer: An analysis of the Testicular Cancer Intergroup Study. J Clin Oncol 1992;10:760-765.
  21. Nichols C, Andersen J, Lazarus H, et al. High dose Carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group Protocol. J Clin Oncol 1992;10:558-563.
  22. Bajorin D, Nichols C, Schmoll H, et al. Recombinant human granulocyte-macrophage colony stimulating factor as an adjunct to conventional dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: A randomized trial. J Clin Oncol 1995;13:79-86.
  23. Broun E, Nichols C, Kneebone P, et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and bone marrow transplantation. Ann Int Med 1992;117:124-128.
  24. Roth B, Nichols C. Victory .... and a new call to arms. Semin Oncol 1992.
  25. Orazi A, Neiman R, Ulbright T, Heerema N, John K, Nichols C. Hematopoietic precursor cells within the yolk sac component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993;71:3873-3881.
  26. Munshi N, Loehrer P, Williams S, et al. Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors. Invest New Drugs 1992;10:159-163.
  27. Case D, Bukowski R, Carey R, et al. Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy. J Natl Cancer Instit 1993;85:801-806.
  28. Nichols C, Breeden E, Loehrer P, Williams S, Einhorn L. Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor trials. J Natl Cancer Inst 1993;85:36-40.
  29. Nichols C, Roth B, Broun E, Loehrer P, Williams S, Einhorn L. Dose intensity in germ cell cancer: continued lessons from a model neoplasm. Eur Urol 1993;23:231-239.
  30. Loehrer P, Elson P, Dreicer R, Hahn R, Nichols C, Einhorn L.  Escalated Dosages of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin plus rhG-CSF in Advanced Urothelial Carcinoma: An Eastern Cooperative Oncology Group Trial..  J Clin Oncol 1994;12:483-488.
  31. Nichols C, Fox E, Roth B, Loehrer P, Williams S, Einhorn L. Incidence of Neutropenic Fever in Patients Treated with Standard Dose Combination Chemotherapy for Small Cell Lung Cancer and the Cost Impact of Treatment with G-CSF.   J Clin Oncol 1994;12:1245-1250.
  32. Zon R, Orazi A, Neiman R, Nichols C.  Benign Hematological Neoplasm Associated with Mature Mediastinal Teratoma in a Patient with Klinefelter's syndrome: A Case Report. Med Pediatr Oncol 1994;23:376-379.
  33. Saxman S, Nichols C, Einhorn L. Salvage Chemotherapy in Patients with Extragonadal Nonseminomatous Germ Cell Tumors: The Indiana University Experience. J Clin Oncol 1994;12:1390-1393.
  34. Blanke C, Loehrer P, Einhorn L, Nichols C. A phase II study of VP-16, ifosfamide, cisplatin, vinblastine and bleomycin in advanced germ cell tumors. Am J Clin Oncol 1996;19:487-491.
  35. Saxman S, Nichols C, Foster R, Messemer J, Donohue J, Einhorn L. The management of patients with clinical stage I non-seminomatous germ cell tumors and persistently elevated serologic markers. J Urology 1995;Submitted.
  36. Development of the International Germ Cell Consensus Classification. J Clin
    Oncol 1997 Feb.
  37. Nichols C, Gonin R, Foster R. Defining new standards for adjuvant therapy of testis cancer. J Clin Oncol 1995;13:2681-2683.
  38. Broun E, Nichols C, Mandanas R, et al. Dose escalation study of high dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors. Bone Marrow Transplant 1995;16:353-358.
  39. Canfield V, Vose J, Guiney P, Bennett, Nichols C. 2-Chlorodeoxyadenosine as initial therapy of advanced low grade lymphoma. Leuk/lymphoma 1996.
  40. Beyer J, Kramar A, Mandanas R, et al.  High dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.  J Clin Oncol 1996 Oct;14(10:2638-24)
  41. Blanke C, Loehrer PJ, Nichols CR, Einhorn LH.  A phase II trial of VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin in advanced germ-cell tumors.  Am  Clin Oncol 1996 Oct;19(5):487-91.
  42. Blanke C, Delgavis S, Nichols C. Late recurrence of seminoma. South Med J 1997;).
  43. Vose J, Pandite A, Beveridge R, et al. PIXY321 (Granulocyte-macrophage colony stimulating factor/interlwukin-3 Fusion Protein) vs Granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for Non-Hodgkin's lymphoma: Results of a randomized double blind trial. J Clin Oncol. 1997 Apr;15(4):1617-23.
  44. Sandler AB, Cristou, A, Fox S, Williams SD, Nichols CR, et al.  A phase II trial of paclitaxel in refractory germ cell tumors.  Cancer 1998 Apr 1;82(7):1381-6.
  45. Broun ER, Nichols CR, Gize G, et al.  Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.  Cancer 1997 Apr 15;79(8):1605-10.
  46. Saxman S, Nichols C, Einhorn L. Pulmonary toxicity in patients with advanced stage germ cell tumors receiving bleomycin with or without granulocyte colony stimulating factor. Chest 1997;111:657-660.
  47. Nichols CR, Loehrer PJ Sr. The story of second cancers in patients cured of testicular cancer: tarnishing success or burnishing irrelevance?  J Natl Cancer Inst.  1997 Oct 1;89(19):1394-5.
  48. Nichols CR, Saxman S.  Primary salvage of recurrent germ cell tumors; experience at Indiana University.  Semin Oncol. 1998 Apr; 25(2):210-4
  49. Nichols CR, Catalano PJ, Crawford ED, et al.  Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an ECOG, SWOG Cancer and Leukemia Group B Study.  J Clin Onc. 1998 Apr:16(4):1287-93.
  50. Porcu P, Nichols C.  Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma. Curr Probl Cancer. 1998 Sep-Oct;22(5):283-368. Review
  51. Nichols C, Catalano P, Loehrer P, Vogelzang N, Crawford E, Einhorn L. Randomized comparison of cisplatin, etoposide and either ifosfamide or bleomycin in advanced germ cell tumors: An ECOG, SWOG, CALGB Intergroup trial. J Clin Oncol 1998
  52. Nichols C, Anderson J, Lazarus H, et al. High dose carboplatin and etoposide with autologous bone marrow transplantation: an Eastern Cooperative Oncology Group protocol. J Clin Oncol Classic Papers and Current Comments 1997;
  53. Zon R, Nichols C, Einhorn L. Management strategies and results in germ cell tumor patients with very high (>50,000 mIU/ml) HCG levels. J Clin Oncol 1998 April Issue
  54. Loehrer PJ, Gonin R, Nichols CR, Weathers T, Einhorn LH.  Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.  J Clin Oncol 16: 1998; 2500-2504
  55. Foster RS, Nichols CR, Testicular Cancer: What’s New in Staging Prognosis and Therapy.  Oncology 13: 1999; 1689-94
  56. M. Fisch, C. Callahan, J. Kesterson, C. Nichols, et al.  The Use of an Electronic Patient Record System to Identify Advanced Cancer Patients and Antidepressant Drug Use.  J. of Palliative Med.  1999;vol 2:403-409.
  57. Nichols CR.  Treatment of Recurrent Germ Cell Tumors.  Semin in Surg Oncol 17: 1999; 268-274.
  58. C. Bokemeyer, C. Kollmannsberger, C. Meisner et al.  First-line high-dose chemotherapy compared with standard dose PEB/VIP Chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. J Clin Oncol 17: 1999;3450-56.
  59. O’Dwyer M, Launder T, Rabkin, Nichols C.  Successful Treatment of Aggressive Post Transplant Lymphoproliferative Disorder using Rituximab.  Leukemia and Lymphoma, Vol. 00, 2000;1-9.
  60. Kollmannsberger C, Nichols C, Bamberg M., et al.  First-line high-dose chemotherapy " radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Annals of Oncol 11:553-559, 2000.
  61. Foster R, Nichols C, Sheinfeld J.  Testicular cancer: Increasing in incidence-and curability.  Patient Care 182-37, May 30, 2000.
  62. J.T. Hartman, C.R. Nichols, J-P. Droz, et al.  Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.  J Nat. Cancer Inst 2000; 92 (1):54-61.
  63. Fizazi K, Tjulandin S, et al.  Viable Malignant Cells After Primary
    Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors:  Prognostic Factors and Role of Post surgery Chemotherapy—Results From an International Study Group. J. Clin Onc, Vol 19, No 10(May 10), 2001: pp2647-2657.
  64. Nichols CR. Chemotherapy of Disseminated Germ Cell Tumors.  Semin Urol
    Onc. 2001: 19 (3): 165-9.
  65. Garzotto M, Nichols C.  Current Concepts in Risk Factor Assessment for
    Advanced Germ Cell Cancer Vol 19, No3, Aug. 2001: pp165-169.
  66. Hartman J, Fossa S, Nichols C, et al.  Incidence of metachronous testicular Cancer
    in Patients with Extragonadal Germ Cell Tumors.  Vol . 93, No. 22, Nov. 22, 2001
    J. of the NCI
  67. Hartmann JT, Nichols CR, Droz JP, et al.  Prognostic variables for response and
    outcome in patients with extragonadal germ-cell tumors,  Ann Oncol 2002; 13: 1017-1028.
  68. Hinton S, Catalano P, Einhorn L, et al.  Re-Analysis of the Intergroup Trial
    (E3887) of Cisplatin and Etoposide and Either Bleomycin or Ifosfamide in the treatment of Disseminated Germ Cell Tumors Using the International Gem Cell Consensus Classification. Cancer. 2003 Apr 15;97(8):1869-75.
  69. Vose JM, Sharp G, Chan, WC, Nichols CR, et al.  Autologous Transplantation for
    Aggressive Non-Hodgkin’s Lymphoma: Results of a Randomized Trial Evaluating Graft Source and Minimal Residual Disease.  J oClin. Onc. Vol 20, May 1, 2002 pp 2344-2352.
  70. Bokemeyer C, Nichols CR, Droz JP, et al.  Extragonadal germ cell tumors of the
    mediastinum and retroperitoneum: results from an international analysis.  J Clin Onc. 2002; 20(7): 1864-73.
  71. Klein CK, Tangen CM, Braun TJ, Hussain MH, Peereboom DM, Nichols CR, et al. SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group Study.  Prostate 2002; 52 (4): 264-8.
  72. Hinton S, Catalano P, Einhorn L, Nichols C, et al.  Cisplatin, Etoposide and Either Bleomycin or Ifosfamide in the treatment of Disseminated Germ Cell Tumors.  Cancer 2003; vol 97 num 8: pp1869-1875. 
  73. Bokemeyer C, Hartman J, Fossa S, et al.  Extragonadal germ cell tumors: relation to testicular neoplasia and management options.  APMIS 111: 49-63 2003.
  74. Karamlou K, Nichols DJ, Nichols CR.   Intensive care unit outcomes in elderly cancer patients.  Crit. Care Clin. 19(4):657-75, 2003 Oct.
  75. Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN) A Southwest Oncology Group phase II study. (Submitted Cancer Investigations 2006) S9902
  76. Kollmannsberger C, Nichols C, Bokemeyer C.  Recent advances in management of patients with platinum-refractory testicular germ cell tumors.  Cancer 2006 Mar 15;106(6):1217-26.
  77. Beer, TM, Tangen CM, Nichols, CR et al. Southwest oncology group phase II study of trioxide in patients with refractory germ cell malignancies. Cancer 2006 May
  78. Einhorn LH, Brames MJ, Dreicer R, Nichols CR, Cullen MT Jr, Bubalo J. Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer.
    Support Care Cancer. 2007 Apr 14; [Epub ahead of print]
  79. Moore CJ, Daneshmand S, Kondagunta GV, Nichols CR. Management of difficult germ-cell tumors.  Oncology (Williston Park). 2006 Nov;20(12):1565-70, 1575; discussion 1575-6. Review.
  80. Lycette JL, Dul CL, Munar M, Belle D, Chui SY, Koop DR, Nichols CR. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report.
    Clin Breast Cancer. 2006 Oct;7(4):342-4.
  81. Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, Bajorin DF, Lara PN Jr, Einhorn L, Mazumdar M, Bosl GJ.Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.  J Clin Oncol. 2007 Jan 20;25(3):247-56.
Home | myProvidence
Notice of Privacy Practices
Site Map | Contact | FAQ


Terms of Use and Privacy Policy | Disclaimer